Inventor
WOLFF HANS-MICHAEL
DE28 patents
⚠️ This page may combine multiple inventors who share the name “WOLFF HANS-MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOL ARZNEI SCHWARZ GMBH
11 patentsUS6562367B1May 13, 2003
Transdermal therapeutic system (TTS) for administering sexual steroid hormones
SANOL ARZNEI SCHWARZ GMBH55 citations95
US6555131B1Apr 29, 2003
Therapeutical system for transdermal delivery of levonorgestrel
SANOL ARZNEI SCHWARZ GMBH60 citations95
US6783769B1Aug 31, 2004
Transdermal therapeutic system TTS containing tolterodine
SANOL ARZNEI SCHWARZ GMBH55 citations94
US6461636B1Oct 8, 2002
Transdermal therapeutic system containing pergolide
SANOL ARZNEI SCHWARZ GMBH72 citations93
US5527536AJun 18, 1996
Active ingredient patch for low-melting and/or volatile active ingredients
SANOL ARZNEI SCHWARZ GMBH43 citations91
US5498418AMar 12, 1996
Nitroglycerine plaster and process for its production
SANOL ARZNEI SCHWARZ GMBH26 citations87
US6555129B1Apr 29, 2003
Transdermal therapeutic system (TTS) containing oxybutynin
SANOL ARZNEI SCHWARZ GMBH14 citations81
US5603948AFeb 18, 1997
Active ingredient patch for low-melting and/or volatile active ingredients
SANOL ARZNEI SCHWARZ GMBH9 citations69
US7632859B2Dec 15, 2009
Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
SANOL ARZNEI SCHWARZ GMBH7 citations65
US7670621B2Mar 2, 2010
Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters
SANOL ARZNEI SCHWARZ GMBH2 citations60
US5817697AOct 6, 1998
Transdermal presentation of nitroglycerin for preventing undesired labor
SANOL ARZNEI SCHWARZ GMBH1 citations45
UCB PHARMA GMBH
5 patentsUS10350174B2Jul 16, 2019
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
UCB PHARMA GMBH1 citations72
US9034914B2May 19, 2015
Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
UCB PHARMA GMBH2 citations57
US10130589B2Nov 20, 2018
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
UCB PHARMA GMBH0 citations51
US7919117B2Apr 5, 2011
Transdermal delivery of (R)-3,3-diphenylpropylamin-monoestern
UCB PHARMA GMBH0 citations49
US7989654B2Aug 2, 2011
High purity bases of 3,3-diphenylpropylamino monoesters
UCB PHARMA GMBH0 citations39
SCHACHT DIETRICH WILHELM
3 patentsUS8617591B2Dec 31, 2013
Transdermal delivery system for the administration of rotigotine
SCHACHT DIETRICH WILHELM31 citations88
US8246979B2Aug 21, 2012
Transdermal delivery system for the administration of rotigotine
SCHACHT DIETRICH WILHELM11 citations79
US8246980B2Aug 21, 2012
Transdermal delivery system
SCHACHT DIETRICH WILHELM1 citations48
LTS LOHMANN THERAPIE SYSTEME AG
3 patentsUS12070521B2Aug 27, 2024
Method for adjusting the release of active agent in a transdermal delivery system
LTS LOHMANN THERAPIE SYSTEME AG0 citations59
US11426359B2Aug 30, 2022
Method for adjusting the release of active agent in a transdermal delivery system
LTS LOHMANN THERAPIE SYSTEME AG0 citations59
US11389410B2Jul 19, 2022
Multi-day patch for the transdermal administration of rotigotine
LTS LOHMANN THERAPIE SYSTEME AG0 citations44